M. Indrová
-
Immunotherapeutic Efficacy of Vaccines Generated by Fusion of Dendritic Cells and HPV16-Associated Tumour Cells
Jana Šímová, J. Bubeník, J. Bieblová, M. Indrová, T. Jandlová
2005, Vol. 51, Issue 1, pp. 19-24 -
Loss of Tumorigenicity of Murine Colon Carcinoma MC38/0 Cell Line after Transduction with a Retroviral Vector Carrying Murine IL-12 Genes
Elżbieta Pajtasz-Piasecka, A. Szyda, J. Rossowska, A. Krawczenko, M. Indrová, P. Grabarczyk, P. Wysocki, A. Mackiewicz, D. Duś
2004, Vol. 50, Issue 1, pp. 7-14
The following name might also represent this author:
Marie Indrová
-
Immunogenicity of Dendritic Cell-Based HPV16 E6/E7 Peptide Vaccines: CTL Activation and Protective Effects
Marie Indrová, M. Reiniš, J. Bubeník, T. Jandlová, J. Bieblová, V. Vonka, J. Velek
2004, Vol. 50, Issue 6, pp. 184-193 -
Adjuvant Cytokine Treatment of Minimal Residual Disease after Surgical Therapy in Mice Carrying HPV16-Associated Tumours: Cytolytic Activity of Spleen Cells from Tumour Regressors
Marie Indrová, R. Mikyšková, T. Jandlová, V. Vonka, J. Bubeník, J. Bieblová
2003, Vol. 49, Issue 6, pp. 217-222
